Inconclusive messages from equivalence trials in thrombolysis

被引：9

作者：

Bertele, V ^{[1
]}

Torri, V

Garattini, S

机构：

[1] Mario Negri Inst Pharmacol Res, Milan, Italy

[2] Consozzio Mario Negri Sud, S Mazia Imbaro, Italy

来源：

HEART | 1999年 / 81卷 / 06期

关键词：

D O I：

10.1136/hrt.81.6.675

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：675 / 676

页数：2

相关论文

共 5 条

[1] ABE O, 1992, LANCET, V339, P71
[2] Drug therapy: Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction
Collins, R
Peto, R
Baigent, C
Sleight, P
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (12) : 847 - 860
[3] *INT JOINT EFF COM, 1995, LANCET, V346, P329
[4] Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: The COMPASS equivalence trial
Tebbe, U
Michels, R
Adgey, J
Boland, J
Caspi, A
Charbonnier, B
Windeler, J
Barth, H
Groves, R
Hopkins, GR
Fennell, W
Betriu, A
Ruda, M
Mlczoch, J
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (03) : 487 - 493
[5] Topol E, 1997, NEW ENGL J MED, V337, P1118